FDA's Chief Science Officer Vinay Prasad Steps Down Amid Controversy
Published on: July 30, 2025, 8:16 a.m. | Source: Devdiscourse
Vinay Prasad, former chief medical and science officer at the FDA, has resigned following controversial decisions about a gene therapy drug by Sarepta Therapeutics. Prasad relinquished his position to spend more time with family, having impacted significant reforms at the FDA during his service.
